SEARCH

SEARCH BY CITATION

References

  • Allinson T. M., Parkin E. T., Turner A. J. and Hooper N. M. (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res. 74, 342352.
  • Ando K., Iijima K. I., Elliott J. I., Kirino Y. and Suzuki T. (2001) Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J. Biol. Chem. 276, 4035340361.
  • Borg J. P., Ooi J., Levy E. and Margolis B. (1996) Phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 62296241.
  • Borg J. P., Yang Y., Taddeo-Borg M., Margolis B. and Turner R. S. (1998) The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion. J. Biol. Chem. 273, 1476114766.
  • Brouillet E., Trembleau A., Galanaud D., Volovitch M., Bouillot C., Valenza C., Prochiantz A. and Allinquant B. (1999) The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction. J. Neurosci. 19, 17171727.
  • Buxbaum J. D., Liu K. N., Luo Y. et al. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretasecleavage of Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 2776527767.
  • Cao X. and Sudhof T. C. (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115120.
  • Cao X. and Sudhof T. C. (2004) Dissection of amyloid beta precursor protein-dependent transcriptional transactivation. J. Biol. Chem. 279, 2460124611.
  • Cattaneo E. and Pelicci P. G. (1998) Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain. Trends Neurosci. 21, 476481.
  • Chang K. A., Kim H. S., Ha T. Y. et al. (2006) Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 26, 43274338.
  • Chow N., Korenberg J. R., Cen X. N. and Neve R. L. (1996) APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J. Biol. Chem. 271, 1133911346.
  • Da Cruz e Silva E. F. and Da Cruz e Silva O. A. (2003) Protein phosphorylation and APP metabolism. Neurochem. Res. 28, 15531561.
  • Dankort D., Maslikowski B., Warner N., Kanno N., Kim H., Wang Z., Moran M. F., Oshima R. G., Cardiff R. D. and Muller W. J. (2001) Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol. Cell. Biol. 21, 15401551.
  • De Strooper B. (2003) Aph-1, Pen-2, and nicastrin with presenilin generate an active gammasecretase complex. Neuron 38, 912.
  • Ermekova K. S., Zambrano N., Linn H., Minopoli G., Gertler F., Russo T. and Sudol M. (1997) The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J. Biol. Chem. 272, 3286932877.
  • Ferrer I., Blanco R., Carmona M. et al. (2001) Phosphorylated map kinase (ERK1, ERK2). expression is associated with early tau deposition in neurons and glial cells but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol. 11, 144158.
  • Feyt C., Pierrot N., Tasiaux B., Van Hees J., Kienlen-Campard P., Courtoy P. J. and Octave J. N. (2007) Phosphorylation of APP695 at Thr668 decrases gamma-cleavage and extracellular Abeta. Biochem. Biophys. Res. Commun. 357, 10041010.
  • Fiore F., Zambrano N., Minopoli G., Donini V., Duilio A. and Russo T. (1995) The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer’s amyloid precursor protein. J. Biol. Chem. 270, 3085330856.
  • Gandy S., Czernik A. J. and Greengard P. (1988) Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase. Proc. Natl Acad. Sci. USA 85, 62186221.
  • Ghosal K., Vogt D. L., Liang M., Shen Y., Lamb B. T. and Pimplikar S. W. (2009) Alzheimer’s disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl Acad. Sci. USA 106, 1836718372.
  • Giambarella U., Yamatsuji T., Okamoto T., Matsui T., Ikezu T., Murayama Y. et al. (1997) G protein beta-gamma complex-mediated apoptosis by familial Alzheimer’s disease mutant of APP. EMBO J. 16, 48974907.
  • Guenette S. Y., Chen J., Ferland A., Haass C., Capell A. and Tanzi R. E. (1999) hFE65L influences amyloid precursor protein maturation and secretion. J. Neurochem. 73, 985993.
  • Guise S., Braguer D., Carles G., Delacourte A. and Briand C. (2001) Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J. Neurosci. Res. 63, 257267.
  • Haas M. R. and Yankner B. A. (2005) A γ-secretase-independent mechanism of signal transduction by the Amyloid Precursor Protein. J. Biol. Chem. 280, 3689536904.
  • Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002, 353356.
  • Hebert S. S., Serneels L., Tolia A., Craessaerts K., Derks C., Filippov M. A., Muller U. and De Strooper B. (2006) Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 7, 739745.
  • Ho C. S., Marinescu V., Steinhilb M. L., Gaut J. R., Turner R. S. and Stuenkel E. L. (2002) Synergistic effect of Munc18a and X11 proteins on amyloid precursor protein metabolism. J. Biol. Chem. 277, 2702127028.
  • Howell B. W., Hawkes R., Soriano P. and Cooper J. A. (1997) Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389, 733737.
  • Iijima K., Ando K., Takeda S., Satoh Y., Seki T., Itohara S., Greengard P., Kirino Y., Nairn A. C. and Suzuki T. (2000) Neuron-specific phosphorylation of Alzheimer’s beta amyloid precursor protein by cyclin-dependent kinase 5. J. Neurochem. 75, 10851091.
  • Inomata H., Nakamura Y., Hayakawa A., Takata H., Suzuki T., Miyazawa K. and Kitamura N. (2003) A scaffold protein JIP-1b enhances amyloid precursor protein phosphorylation by JNK and its association with kinesin light chain 1. J. Biol. Chem. 278, 2294622955.
  • Kamal A., Stokin G. B., Yang Z., Xia C. H. and Goldstein L. S. (2000) Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28, 449459.
  • Kamal A., Almenar-Queralt A., LeBlanc J. F., Roberts E. A. and Goldstein L. S. (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414, 643648.
  • Kinoshita A., Whelan C. M., Smith C. J., Mikhailenko I., Rebeck G. W., Strickland D. K. and Hyman B. T. (2001) Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. J. Neurosci. 21, 83548361.
  • Lambrechts A., Kwiatkowski A. V., Lanier L. M., Bear J. E., Vandekerckhove J., Ampe C. and Gertler F. B. (2000) cAMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J. Biol. Chem. 275, 3614336151.
  • Lee M., Kao S., Lemere C., Xia W., Tseng H., Zhou Y., Neve R., Ahlijanian M. and Tsai L. (2003) APP processing is regulated by cytoplasmic phosphorylation. J. Cell Biol. 163, 8395.
  • Lowenstein E. J., Daly R. J., Batzer A. G., Li W., Margolis B., Lammers R. et al. (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70, 431442.
  • Luzi L., Confalonieri S., Di Fiore P. P. and Pelicci P. G. (2000) Evolution of Shc functions from nematode to human. Curr. Opin. Genet. Dev. 10, 668674.
  • Masin M., Kerschensteiner D., Dümke K., Rubio M. E. and Soto F. (2006) Fe65 interacts with P2X2 subunits at excitatory synapses and modulates receptor function. J. Biol. Chem. 281, 41004108.
  • McPhie D. L., Coopersmith R., Hines-Peralta A., Chen Y., Ivins K. J., Manly S. P., Kozolowski M. R., Neve K. A. and Neve R. L. (2003) DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J. Neurosci. 23, 69146927.
  • Migliaccio E., Mele S., Salcini A. E. et al. (1997) Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 16, 706716.
  • Nakaya T. and Suzuki T. (2006) Role of APP phosphorylation in Fe65-dependent gene transactivation mediated by AICD. Gene Cells 11, 633645.
  • Neve R. L. and McPhie D. L. (2006) The cell cycle as a therapeutic target for Alzheimer’s disease. Pharmacol. Ther. 111, 99113.
  • Nizzari M., Venezia V., Repetto E. et al. (2007) Amyloid precursor protein and presenilin 1 interact with the adaptor GRB2 and modulate ERK1,2 signalling. J. Biol. Chem. 282, 1383313844.
  • Oishi M., Nairn A. C., Czernik A. J., Lim G. S., Isohara T., Gandy S. E., Greengard P. and Suzuki T. (1997) The cytoplasmic domain of Alzheimer’s amyloid precursor protein is phosphorylated at Thr 654, Ser 655 and Thr 668 in adult rat brain and cultured cells. Mol. Med. 3, 111123.
  • Parisiadou L. and Efthimiopoulos S. (2007) Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11α. Neurobiol. Aging 28, 377388.
  • Pelicci G., Troglio F., Bodini A., Melillo R. M., Pettirossi V., Coda L., De Giuseppe A., Santoro M. and Pelicci P. G. (2002) The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. Mol. Cell. Biol. 22, 73517363.
  • Pietrzik C. U., Yoon I. S., Jaeger S., Busse T., Weggen S. and Koo E. H. (2004) FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J. Neurosci. 24, 42594265.
  • Puto L. A., Pestonjamasp K., King C. C. and Bokoch G. M. (2003) p21-activated kinase 1 (PAK1) Interacts with the Grb2 adapter protein to couple to growth factor signaling. J. Biol. Chem. 278, 93889393.
  • Raychaudhuri M. and Mukhopadhyay D. (2007) AICD and its adaptors – in search of new players. J. Alzheimer’s Dis. 11, 343358.
  • Roder H. M., Eden P. A. and Ingram V. M. (1993) Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer’s disease. Biochem. Biophys. Res. Commun. 193, 639647.
  • Rogelj B., Mitchell J. C., Miller C. C. and McLoughlin D. M. (2006) The X11/Mint family of adaptor proteins. Brain Res. Brain Res. Rev. 52, 305315.
  • Roncarati R., Sestan N., Scheinfeld M. H., Berechid B. E., Lopez P. A., Meucci O., McGlade J. C., Rakic P. and D’adamio L. (2002) The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc. Natl Acad. Sci. USA 99, 71027107.
  • Russo C., Salis S., Dolcini V., Venezia V., Song X. H., Teller J. K. and Schettini G. (2001) Amino-terminal modification and tyrosine phosphorylation of (corrected) carboxy-terminal fragments of the amyloid precursor protein in Alzheimer’s disease and Down’s syndrome brain. Neurobiol. Dis. 8, 173180.
  • Russo C., Dolcini V., Salis S., Venezia V., Zambrano N., Russo T. and Schettini G. (2002) Signal transduction through tyrosine-phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer’s disease brain. J. Biol. Chem. 277, 3528235288.
  • Russo C., Venezia V., Repetto E., Nizzari M., Violani E., Carlo P. and Schettini G. (2005) The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications. Brain Res. Brain Res. Rev. 48, 257264.
  • Sabo S. L., Lanier L. M., Ikin A. F., Khorkova O., Sahasrabudhe S., Greengard P. and Buxbaum J. D. (1999) Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J. Biol. Chem. 274, 79527957.
  • Sabo S. L., Ikin A. F., Buxbaum J. D. and Greengard P. (2001) The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153, 14031414.
  • Sabo S. L., Ikin A. F., Buxbaum J. D. and Greengard P. (2003) The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J. Neurosci. 23, 54075415.
  • Santiard-Baron D., Langui D., Delehedde M. et al. (2005) Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. J. Neurochem. 93, 330338.
  • Sastre M., Turner R. S. and Levy E. (1998) X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J. Biol. Chem. 273, 2235122357.
  • Saucier C., Papavasiliou V., Palazzo A., Naujokas M. A., Kremer R. and Park M. (2002) Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis. Oncogene 21, 18001811.
  • Scheinfeld M. H., Roncarati R., Vito P., Lopez P. A., Abdallah M. and D’Adamio L. (2002) Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer’s beta-amyloid precursor protein (APP). J. Biol. Chem. 277, 37673775.
  • Schenfield M. H., Ghersi E., Davies P. and D’Adamio L. (2003) Amyloid beta protin precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1. J. Biol. Chem. 278, 4205842063.
  • Selkoe D. J. (2002) Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J. Clin. Invest. 110, 13751381.
  • Sudol M., Sliwa K. and Russo T. (2001) Functions of WW domains in the nucleus. FEBS Lett. 490, 190195.
  • Suzuki T., Oishi M., Marshak D. R., Czernik A. J., Nairn A. C. and Greengard P. (1994) Cell cycle-dependent regulation of phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 13, 11141122.
  • Suzuki T., Ando K., Isohara T. et al. (1997) Phosphorylation of Alzheimer beta-amyloid precursor-like protein. Biochemistry 36, 46434649.
  • Takahashi K., Niidome T., Akaike A., Kihara T. and Sugimoto H. (2008) Phosphorylation of amyloid prcursor protein (APP) at Tyr687 regulates APP processing by α- and γ-secretase. Biochem. Biophys. Res. Commun. 377, 544549.
  • Tarr P. E., Contursi C., Roncarati R., Noviello C., Ghersi E., Scheinfeld M. H., Zambrano N., Russo T. and D’Adamio L. (2002a) Evidence for a role of the nerve growth factor receptor TrkA in tyrosine phosphorylation and processing of beta-APP. Biochem. Biophys. Res. Commun. 295, 324329.
  • Tarr P. E., Roncarati R., Pelicci G., Pelicci P. G. and D’Adamio L. (2002b) Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J. Biol. Chem. 277, 1679816804.
  • Taru H., Iijima K., Hase M., Kirino Y., Yagi Y. and Suzuki T. (2002a) Interaction of Alzheimer’s beta amyloid precursor family proteins with scaffold proteins of the JNK signalling cascade. J. Biol. Chem. 277, 2007020078.
  • Taru H., Kirino Y. and Suzuki T. (2002b) Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J. Biol. Chem. 277, 2756727574.
  • Trinei M., Giorgio M., Cicalese A. et al. (2002) A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 21, 38723878.
  • Trommsdorff M., Borg J. P., Margolis B. and Herz J. (1998) Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 3355633560.
  • Vassar R. (2004) BACE1: the beta-secretase enzyme in Alzheimer’s disease. J. Mol. Neurosci. 23, 105114.
  • Vazquez M. C., Vargas L. M., Inestrosa N. C. and Alvarez A. R. (2009) c-Abl modulates AICD dependent cellular responses: transcriptional induction and apoptosis. J. Cell. Physiol. 220, 136143.
  • Venezia V., Russo C., Repetto E., Salis S., Dolcini V., Genova F., Nizzari M., Mueller U. and Schettini G. (2004a) Apoptotic cell death influences the signalling activity of the amyloid precursor protein through ShcA and Grb2 adaptor ptoteins in neuroblastoma SH-SY5Y cells. J. Neurochem. 90, 13591370.
  • Venezia V., Russo C., Repetto E., Nizzari M., Violani E., Carlo P. et al. (2004b) Apoptotic cell death and amyloid precursor protein signalling in neuroblastoma SH-SY5Y cells. Ann. NY Acad. Sci. 1030, 339347.
  • Ventura A., Luzi L., Pacini S., Baldari C. T. and Pelicci P. Gl. (2002) The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J. Biol. Chem. 277, 2237022376.
  • Vogt D. L., Thomas D., Galvan V., Bredsen D. E., Lamb B. T. and Pimpilkar S. W. (2010) Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol. Aging (in press).
  • Zambrano N., Minopoli G., De Candia P. and Russo T. (1998) The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J. Biol. Chem. 273, 2012820133.
  • Zambrano N., Bruni P., Minopoli G., Mosca R., Molino D., Russo C., Schettini G. and Russo T. (2001) The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene. J. Biol. Chem. 276, 1978719792.
  • Zhou D., Noviello C., D’Ambrosio C., Scaloni A. and D’Adamio L. (2004) Growth factor receptor bound protein 2 interaction with the tyrosine-phosphorylated tail of amyloid beta precursor protein is mediated by its Src homology 2 domain. J. Biol. Chem. 279, 2537425380.
  • Zhu X., Lee H. G., Raina A. K., Perry G. and Smith M. A. (2002) The role of mitogen-activated protein kinase pathways in Alzheimer disease. Neurosignals 11, 270281.